Beijing banned imports of Illumina’s gene-sequencing machines in response to U.S. tariffs.

The San Diego company also lowered its financial guidance for 2025 in response to China’s import restrictions.

Gene-sequencing giant Illumina is laying off 96 employees from its San Diego headquarters, according to paperwork filed with ...

Illumina Inc. (NASDAQ:ILMN), a leading provider of next-generation sequencing (NGS) technology with annual revenue of $4.37 billion, finds itself at a critical juncture as it navigates a shifting ...

Amid increasing economic tensions with the United States, China recently announced that it would ban Illumina, a U.S.-based company and the ...

China banned the import of Illumina Inc. gene-sequencing machines as part of a wave of retaliatory trade measures in response ...

Illumina, Inc. (Nasdaq: ILMN) ("Illumina" or the "company") today responded to the March 4, 2025 notice from the China Ministry of Commerce ("MOFCOM") that Illumina is not permitted to export ...

Illumina Inc. (NASDAQ:ILMN), a leading provider of next-generation sequencing (NGS) technology with annual revenue of $4.37 billion, finds itself at a critical juncture as it navigates a shifting ...

Illumina on Monday lowered its annual forecast and said it plans to cut $100 million in spending after China announced a ban ...

GlobalData’s senior medical analyst says the ban will add to a downward trend for Illumina in the Chinese market.

Illumina is not banned from operating in the country and will continue to serve its existing customers, a company ...

Illumina has been barred from exporting its DNA sequencers to China, which closed | Illumina has been barred from exporting ...